| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | BLFS Biolife Solutions, Inc. | Foster Karen A.67 | Chief Quality And Operations | Sell | 2,577 | $19.17 | $49,401.09 | -2.3% | +35.8% | - | |
| Mar 20, 2026 | STIM Neuronetics, Inc. | Chernett Jorey60 | 10% Owner | Buy | 169,472 | $1.41 | $238,955.52 | +2.0% | -15.2% | - | |
| Mar 20, 2026 | OSUR Orasure Technologies, Inc. | McGrath Kenneth J49 | Chief Financial Officer | Buy | 32,300 | $2.93 | $94,600.24 | +5.8% | +44.1% | - | |
| Mar 20, 2026 | OSUR Orasure Technologies, Inc. | Eglinton Manner Carrie | President &CEO | Buy | 32,300 | $2.93 | $94,597.01 | +1.5% | +44.1% | - | |
| Mar 20, 2026 | VMD Viemed Healthcare, Inc. | Moore Michael | President | Sell | 136,802 | $9.05 | $1,237,976.12 | -2.7% | +22.2% | - | |
| Mar 19, 2026 | STIM Neuronetics, Inc. | Chernett Jorey60 | 10% Owner | Buy | 1,057,400 | $1.34 | $1,418,490.00 | +6.8% | -20.1% | - | |
| Mar 17, 2026 | STIM Neuronetics, Inc. | Chernett Jorey60 | 10% Owner | Buy | 531,000 | $1.16 | $615,960.00 | +7.6% | +8.6% | - | |
| Mar 17, 2026 | HBIO Harvard Bioscience, Inc. | Denelsky Stephen J | Director | Buy | 10,000 | $4.87 | $48,700.00 | +90.9% | +24.8% | - | |
| Mar 17, 2026 | HBIO Harvard Bioscience, Inc. | Snider William | Director | Buy | 21,000 | $4.93 | $103,603.50 | +60.8% | +24.8% | - | |
| Mar 16, 2026 | EKSO Ekso Bionics Holdings, Inc. | Jones Jason C64 | Chief Operating Officer | Buy | 1,308 | $11.85 | $15,499.80 | +41.6% | - | - | |
| Mar 16, 2026 | MYO Myomo, Inc. | Getz Heather C52 | Director | Buy | 20,000 | $0.70 | $13,972.00 | +17.9% | +55.4% | - | |
| Mar 16, 2026 | HBIO Harvard Bioscience, Inc. | Frost Mark T | Chief Financial Officer | Buy | 5,000 | $5.00 | $25,000.00 | +40.0% | +21.4% | - | |
| Mar 16, 2026 | EKSO Ekso Bionics Holdings, Inc. | Wong Jerome55 | Chief Financial Officer | Buy | 1,308 | $11.85 | $15,499.80 | +45.5% | - | - | |
| Mar 13, 2026 | ATEC Alphatec Holdings, Inc. | Lish Scott61 | Chief Operating Officer | Sell | 260,535 | $12.30 | $3,204,580.50 | -24.2% | -33.8% | - | |
| Mar 13, 2026 | ATEC Alphatec Holdings, Inc. | Koning John Todd57 | Chief Financial Officer | Sell | 79,789 | $12.36 | $986,192.04 | -11.7% | -33.8% | - | |
| Mar 13, 2026 | SENS Senseonics Holdings, Inc. | Roeder Douglas A69 | Director | Buy | 17,500 | $5.73 | $100,275.00 | +17.1% | +30.0% | - | |
| Mar 13, 2026 | SENS Senseonics Holdings, Inc. | Goodnow Timothy T76 | President And CEO | Buy | 17,225 | $5.79 | $99,732.75 | +2.7% | +30.0% | - | |
| Mar 13, 2026 | NMTC Neuroone Medical Technologies Corporation | Christianson Mark67 | Business Development Director | Sell | 917 | $0.80 | $733.60 | -0.2% | +331.4% | - | |
| Mar 12, 2026 | AHCO Adapthealth Corp. | Oep VII Gp, L.l.c.57 | 10% Owner | Buy | 2,046,691 | $9.73 | $19,912,147.84 | +4.7% | +1.8% | - | |
| Mar 12, 2026 | MYO Myomo, Inc. | Getz Heather C52 | Director | Buy | 70,000 | $0.73 | $50,960.00 | +167.6% | +123.8% | - | |
| Mar 12, 2026 | SIBN Si-Bone, Inc. | Nishimura Mika | Director | Sell | 4,100 | $13.83 | $56,700.13 | -11.1% | +11.2% | - | |
| Mar 12, 2026 | ATRC Atricure, Inc. | Doraiswamy Vinayak70 | Chief Scientific Officer | Sell | 5,000 | $29.83 | $149,150.00 | -4.9% | -6.9% | - | |
| Mar 12, 2026 | AHCO Adapthealth Corp. | Cashin Richard M Jr73 | 10% Owner | Buy | 2,046,691 | $9.73 | $19,912,147.84 | +4.7% | +1.8% | - | |
| Mar 11, 2026 | EW Edwards Lifesciences Corporation | Lippis Daniel J.61 | Cvp, Tavr | Sell | 1,019 | $85.38 | $87,004.46 | -2.9% | +2.9% | - | |
| Mar 11, 2026 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 1,517 | $2.04 | $3,094.68 | -1.0% | +10.4% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.